John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 8,816 shares at $1.75 ($15K) on 2023-01-11, disclosed to the SEC on 2023-01-12.
Seasonal sale ($15k) by Chief Patient Supply Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 3,843 | $7K | 44.2% |
| 2 | $1.71 | 4,973 | $9K | 55.8% |
| Total | $1.73 avg | 8,816 | $15K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-17 | $16K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |